DEXCOM INC. DL-,001/ US2521311074 /
5/17/2024 5:45:20 PM | Chg. +1.98 | Volume | Bid5:53:10 PM | Ask5:53:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.82EUR | +1.67% | 30 Turnover: 3,624.60 |
120.90Bid Size: 330 | 121.22Ask Size: 330 | 48.19 bill.EUR | - | - |
GlobeNewswire
4/8
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
1/31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.